METiS剂泰医药将在11月6-10日于美国休斯敦举行的第39届癌症免疫治疗学会（SITC）年会上，以壁报形式展示在肝靶向递送技术领域的创新研究成果。
报告标题: Organ-Specific Delivery of a mRNA-Encoded Bispecific T Cell Engager Targeting Glypican-3 in Hepatocellular Carcinoma
展示环节一：Immune Engineering Workshop Session IV: Poster Session 地点：George R. Brown Convention Center – Level 3 – Grand Ballroom A时间：Thursday, Nov. 7 at 3:10–5 p.m.展示环节二：Annual Meeting Poster Presentations地点：George R. Brown Convention Center – Level 1 – Exhibit Halls AB时间：Saturday, Nov. 9 from 12:15–6:30 p.m.
